158 related articles for article (PubMed ID: 33657051)
1. The Angiotensin II Type 1(AT1) Receptor and Cardiac Hypertrophy: Did We Have It Wrong All Along?
Zouein FA; Altara R; Massoud GP; Booz GW
J Cardiovasc Pharmacol; 2021 May; 77(5):531-535. PubMed ID: 33657051
[TBL] [Abstract][Full Text] [Related]
2. Direct Actions of AT
Sparks MA; Rianto F; Diaz E; Revoori R; Hoang T; Bouknight L; Stegbauer J; Vivekanandan-Giri A; Ruiz P; Pennathur S; Abraham DM; Gurley SB; Crowley SD; Coffman TM
Hypertension; 2021 Feb; 77(2):393-404. PubMed ID: 33390039
[TBL] [Abstract][Full Text] [Related]
3. The renin-angiotensin system and experimental heart failure.
Wollert KC; Drexler H
Cardiovasc Res; 1999 Sep; 43(4):838-49. PubMed ID: 10615411
[TBL] [Abstract][Full Text] [Related]
4. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
[TBL] [Abstract][Full Text] [Related]
5. Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice.
Harada K; Komuro I; Shiojima I; Hayashi D; Kudoh S; Mizuno T; Kijima K; Matsubara H; Sugaya T; Murakami K; Yazaki Y
Circulation; 1998 May; 97(19):1952-9. PubMed ID: 9609089
[TBL] [Abstract][Full Text] [Related]
6. Insights into the activation and inhibition of angiotensin II type 1 receptor in the mechanically loaded heart.
Wu J; You J; Wang S; Zhang L; Gong H; Zou Y
Circ J; 2014; 78(6):1283-9. PubMed ID: 24813328
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy.
Hoffmann S; Krause T; van Geel PP; Willenbrock R; Pagel I; Pinto YM; Buikema H; van Gilst WH; Lindschau C; Paul M; Inagami T; Ganten D; Urata H
J Mol Med (Berl); 2001 Oct; 79(10):601-8. PubMed ID: 11692158
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney.
Crowley SD; Gurley SB; Herrera MJ; Ruiz P; Griffiths R; Kumar AP; Kim HS; Smithies O; Le TH; Coffman TM
Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17985-90. PubMed ID: 17090678
[TBL] [Abstract][Full Text] [Related]
9. Stearoyl-CoA Desaturase (SCD) Induces Cardiac Dysfunction with Cardiac Lipid Overload and Angiotensin II AT1 Receptor Protein Up-Regulation.
Abd Alla J; Jamous YF; Quitterer U
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576047
[TBL] [Abstract][Full Text] [Related]
10. Comparison of type 1 angiotensin II receptor blockers and angiotensin converting enzyme inhibitors in the treatment of hypertension.
Weber MA
J Hypertens Suppl; 1997 Dec; 15(6):S31-6. PubMed ID: 9493125
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
Ainscough JF; Drinkhill MJ; Sedo A; Turner NA; Brooke DA; Balmforth AJ; Ball SG
Cardiovasc Res; 2009 Feb; 81(3):592-600. PubMed ID: 18703536
[TBL] [Abstract][Full Text] [Related]
12. Guanylyl cyclase-A inhibits angiotensin II type 2 receptor-mediated pro-hypertrophic signaling in the heart.
Li Y; Saito Y; Kuwahara K; Rong X; Kishimoto I; Harada M; Adachi Y; Nakanishi M; Kinoshita H; Horiuchi M; Murray M; Nakao K
Endocrinology; 2009 Aug; 150(8):3759-65. PubMed ID: 19372206
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats.
Nickenig G; Laufs U; Schnabel P; Knorr A; Paul M; Böhm MP
Br J Pharmacol; 1997 May; 121(1):134-40. PubMed ID: 9146897
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin type 1 receptor blockade prevents cardiac remodeling in mice with pregnancy-associated hypertension.
Sakairi A; Ishida J; Honjo K; Inaba S; Nakamura S; Sugiyama F; Yagami K; Fukamizu A
Hypertens Res; 2008 Dec; 31(12):2165-75. PubMed ID: 19139606
[TBL] [Abstract][Full Text] [Related]
15. A newly developed angiotensin II type 1 receptor antagonist, CS866, promotes regression of cardiac hypertrophy by reducing integrin beta1 expression.
Jia N; Okamoto H; Shimizu T; Chiba S; Matsui Y; Sugawara T; Akino M; Kitabatake A
Hypertens Res; 2003 Sep; 26(9):737-42. PubMed ID: 14620930
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin blocking drugs and the heart beyond 2000.
Morgan TO; Delbridge LM
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S243-7. PubMed ID: 9892172
[TBL] [Abstract][Full Text] [Related]
17. AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats.
Nagata K; Somura F; Obata K; Odashima M; Izawa H; Ichihara S; Nagasaka T; Iwase M; Yamada Y; Nakashima N; Yokota M
Hypertension; 2002 Aug; 40(2):168-74. PubMed ID: 12154108
[TBL] [Abstract][Full Text] [Related]
18. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
Carnovali M
Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
[TBL] [Abstract][Full Text] [Related]
19. Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and cardiac remodelling.
Zhu YC; Zhu YZ; Lu N; Wang MJ; Wang YX; Yao T
Clin Exp Pharmacol Physiol; 2003 Dec; 30(12):911-8. PubMed ID: 14678229
[TBL] [Abstract][Full Text] [Related]
20. The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy.
D'Amore A; Black MJ; Thomas WG
Hypertension; 2005 Dec; 46(6):1347-54. PubMed ID: 16286564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
